PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
본 발명은 N-[2,4-비스(1,1-디메틸에틸)-5-히드록시페닐]-1,4-디히드로-4-옥소퀴놀린-3-카르복스아미드의 고체 분산물을 포함하는 제약 조성물, 본 발명의 제약 조성물의 제조 방법 및 본 발명의 제약 조성물의 투여 방법에 관한 것이다. The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquino...
Saved in:
| Main Authors | , , , , , , , , |
|---|---|
| Format | Patent |
| Language | English Korean |
| Published |
30.12.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 본 발명은 N-[2,4-비스(1,1-디메틸에틸)-5-히드록시페닐]-1,4-디히드로-4-옥소퀴놀린-3-카르복스아미드의 고체 분산물을 포함하는 제약 조성물, 본 발명의 제약 조성물의 제조 방법 및 본 발명의 제약 조성물의 투여 방법에 관한 것이다.
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention. |
|---|---|
| AbstractList | 본 발명은 N-[2,4-비스(1,1-디메틸에틸)-5-히드록시페닐]-1,4-디히드로-4-옥소퀴놀린-3-카르복스아미드의 고체 분산물을 포함하는 제약 조성물, 본 발명의 제약 조성물의 제조 방법 및 본 발명의 제약 조성물의 투여 방법에 관한 것이다.
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention. |
| Author | HURTER PATRICIA GROOTENHUIS PETER D. J YOUNG CHRISTOPHER BOTFIELD MARTYN ROWE WILLIAM DINEHART KIRK VERWIJS MARINUS JACOBUS OVERHOFF KIRK GROSSI ALFREDO |
| Author_xml | – fullname: OVERHOFF KIRK – fullname: GROOTENHUIS PETER D. J – fullname: GROSSI ALFREDO – fullname: ROWE WILLIAM – fullname: HURTER PATRICIA – fullname: YOUNG CHRISTOPHER – fullname: DINEHART KIRK – fullname: VERWIJS MARINUS JACOBUS – fullname: BOTFIELD MARTYN |
| BookMark | eNrjYmDJy89L5WQwC_BwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PdTcPRzUXB08fX08wwOCXIECQUrhHi4Brn6u_EwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUknjvICMDQ0sDQxNjE0tzR2PiVAEA6Ykq9w |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 제약 조성물 및 그의 투여 |
| ExternalDocumentID | KR20190143497A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20190143497A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:48:18 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20190143497A3 |
| Notes | Application Number: KR20197037948 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191230&DB=EPODOC&CC=KR&NR=20190143497A |
| ParticipantIDs | epo_espacenet_KR20190143497A |
| PublicationCentury | 2000 |
| PublicationDate | 20191230 |
| PublicationDateYYYYMMDD | 2019-12-30 |
| PublicationDate_xml | – month: 12 year: 2019 text: 20191230 day: 30 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | VERTEX PHARMACEUTICALS INCORPORATED |
| RelatedCompanies_xml | – name: VERTEX PHARMACEUTICALS INCORPORATED |
| Score | 3.2099185 |
| Snippet | 본 발명은 N-[2,4-비스(1,1-디메틸에틸)-5-히드록시페닐]-1,4-디히드로-4-옥소퀴놀린-3-카르복스아미드의 고체 분산물을 포함하는 제약 조성물, 본 발명의 제약 조성물의 제조 방법 및 본 발명의 제약 조성물의 투여 방법에 관한 것이다.
The present invention... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191230&DB=EPODOC&locale=&CC=KR&NR=20190143497A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp-LHlILSt2KpXeseinRJSufoB7WTvY2m6WAo63AV_30vYdM97S3JwZEELve7JPc7gAdEEIXDhTAcU1gGQmphcNuZGdwthXD7lTAV400UO-HYfp30Ji343OTCKJ7QH0WOiBZVor036rxe_l9iUfW3cvXI5zhUvwS5R_V1dIzBB0JqnQ48liY0IToh3ijT40zJJJWd3Xf9PdiXQFoy7bP3gcxLWW47leAEDlLUt2hOofVRd-CIbGqvdeAwWj95Y3NtfaszcNLQzyKfsHEuWQw0kkRp8jaUl0yaH1PNp9EwHsoqyCo3WMtDlrEkOIf7gOUkNHAC07_1TkfZ9myfLqC9qBfVJWiWOStmltPvIYiwq7IquLTHZ_RzJRe9UlxBd5em693iGziWXcViaHah3Xx9V7focRt-pzbqF8hDgBI |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsWPqQWlb8Wytal7KNKlLa1bP6id7G0sTQeirMNV_Pe9hE33tLeQg-MSuNzvLrlfAB4QQcwI41wjOu9qCKm5xgwy15hVcG71S65LxpsoJsHYeJmYkwZ8bnphJE_ojyRHRI8q0N9reV4v_4tYrnxbuXpk7zhVPfu57arr7BiTD4TUqjuwvTRxE6pSag8zNc6kTFDZGX3L2YN9S_DzCvD0NhB9KcvtoOIfw0GK-hb1CTQ-qja06ObvtTYcRusrbxyuvW91CiQNnCxyqDfOBYuBQpMoTV5DUWRSnNhVHDcK41D8gix7g5U88DIv8c_g3vdyGmhowPRvvdNhtm1t7xyai2pRXoDS1eezeZf0TQQRRlmUMyb88QnjXMG4WfBL6OzSdLVbfAetII9G01EYD6_hSIgko6HegWb99V3eYPSt2a3ctF_t7YL_ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION+AND+ADMINISTRATIONS+THEREOF&rft.inventor=OVERHOFF+KIRK&rft.inventor=GROOTENHUIS+PETER+D.+J&rft.inventor=GROSSI+ALFREDO&rft.inventor=ROWE+WILLIAM&rft.inventor=HURTER+PATRICIA&rft.inventor=YOUNG+CHRISTOPHER&rft.inventor=DINEHART+KIRK&rft.inventor=VERWIJS+MARINUS+JACOBUS&rft.inventor=BOTFIELD+MARTYN&rft.date=2019-12-30&rft.externalDBID=A&rft.externalDocID=KR20190143497A |